IL33 and systemic sclerosis: Luzina et al. showed in a mouse model of bleomycin-induced SSc-ILD that extracellular HSP70 (eHSP70) levels were enhanced in association with IL33, a maker correlated with pulmonary fibrosis severity in sera of SSc patients [44].